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background: Biomarkers to predict recurrent stroke are lacking. Elevated levels of oxidized phospholipids on apolipoprotein B-100 
lipoprotein (OxPL/apoB) predict increased risk in patients without and with prior cardiovascular events, but have not been evaluated in 
patients with prior cerebrovascular events.
Methods: In a random sample from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial, OxPL/apoB 
levels were measured in 3017 patients with stroke or transient ischemic attacks within the last 6 months of enrollment at baseline and in 
1738 patients at 5-years after being randomized to placebo or atorvastatin 80mg. The change in OxPL/apoB with atorvastatin therapy and 
the association between OxPL/apoB and recurrent cerebrovascular events was examined.
Results: Patients with recurrent cerebrovascular events had higher baseline levels of OxPL/apoB than those without events (17.9 vs 17.3 
nM in median, p=0.019). Baseline levels of OxPL/apoB predicted recurrent cerebrovascular events (hazard ratio, 95% confidence interval 
(HR, 95% CI) 1.54 (1.18-2.00, p=0.0014) comparing the highest quartile to lowest quartile. This HR was 1.81 (1.27-2.58, p=0.0011) in the 
placebo group, and 1.26 (0.85-1.87, p=0.252).
conclusion:  Elevated OxPL/apoB levels predict recurrent cerebrovascular events in patients with prior stroke or transient ischemic attack 
and high dose atorvastatin significantly decreased this risk.
